Lumakras, an oral drug, is specifically designed to target a mutated form of the KRAS gene, occurring in approximately 13 per cent of non-small cell lung cancers, the most prevalent form of lung cancer, and less frequently in some other solid tumours
Read More
Reportedly, Novo Nordisk, the manufacturer of Ozempic, is collaborating with the FDA to conduct testing on the seized counterfeit shots
Read More
Varenicline tablets, 0.5 mg, and 1 mg will serve as a generic equivalent to Chantix Tablets, 0.5 mg, and 1 mg which will be produced at Lupin's unit in Pithampur
Read More
The World Health Organization (WHO) had previously granted emergency use authorisation for the vaccine last month, which is tailored to address a descendant of the XBB lineage of the coronavirus
Read More
The FDA has issued another warning letter to Intas Pharmaceuticals, citing manufacturing violations, quality control lapses, and compromised data integrity at its plant in Ahmedabad, Gujarat, India. The FDA has also added the Indian facility to its import alert list, allowing FDA field operatives to detain products from Intas without physical examination
Read More
GlobalData's Device Approval Analyser Database indicates an average timeline of 5.9 years for test development in the US, while the approval process for devices takes eight to 13 months
Read More
This latest endorsement by the FDA comes after the initial accelerated approval granted on January 27 for Jaypirca's efficacy in treating mantle cell lymphoma (MCL)
Read More
Tacrolimus, an immunosuppressive medication crucial for minimising the risk of organ rejection post-transplant, is now priced at Rs 20.97 for 0.5 mg, Rs 39.98 for 1 mg, and Rs 77.69 for 2 mg. Additionally, the NPPA has fixed the ceiling price for Co-trimoxazole, a medication used to treat various bacterial infections, at Rs 2.30
Read More
